HOME >> MEDICINE >> NEWS
Progress toward an antitumor vaccine

carbon atoms coupled together through a sulfur atom). To this end, the carrier protein is first equipped with a spacer, which has an allyl group (two carbon atoms attached by a double bond) at its end. The glycopeptide is coupled to a building block that causes thiols (sulfurhydrogen groups) to protrude from the molecule. In the next, light-initiated (photochemical) reaction, only the desired thioether bonds are formedno side reactions occur at other locations in the peptide chain.

Synthetic glycopeptide antigens containing structural elements typical of tumors in the sugar as well as the protein segment, explains Kunz, can thus be attached to the carrier protein in a controlled fashion. The largely nonimmunogenic thioether bridges could clear the way for the development of vaccines for immunization against tumor cells.


'"/>

Contact: Horst Kunz
hokunz@mail.uni-mainz.de
49-613-139-22334
John Wiley & Sons, Inc.
13-Jun-2007


Page: 1 2

Related medicine news :

1. Malaria 2007 -- Progressing research, persisting challenges
2. March 30 public briefing on PEPFARs Progress
3. Progression of diabetic retinopathy among African-Americans with diabetes
4. Progress slow in improving hospitals patient safety systems
5. Progress conference on child survival as called for in 2003 Lancet series to take place next week
6. Albert Szent-Gyrgyi Prize for Progress in Cancer Research to Harvards Harold F. Dvorak, M.D.
7. Free public talk on epilepsy research and progress towards better treatment
8. New study in Sleep finds a high level of negativity towards judicial sleepiness
9. Kenya moves toward national food and nutrition policy
10. A sweet step toward new cancer therapies
11. Comprehensive reforms to move toward patient-centered care released by ACP

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progress toward antitumor vaccine

(Date:4/17/2014)... LSTM have called for more research to be ... children in sub-Saharan Africa. In a paper in ... Russell Stothard, working with colleagues in the department ... University, in Cleveland Ohio, University of Cambridge and ... into the joint burden of HIV/AIDS and schistosomiasis ...
(Date:4/16/2014)... NJ (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: ... 1 study of CDX-1401 in solid tumors, including long-term ... Medicine (Vol 6 Issue 232). The data demonstrate ... clinical benefit in patients with very advanced cancers and ...
(Date:4/16/2014)... While it is well known that fertility treatments are ... that multiples are at elevated risk of premature birth, ... Fertility and Sterility . The article ... reduce the odds of multiple births and prematurity, including ...
(Date:4/15/2014)... medical mystery and in the process have found a potentially ... 1.5 million people a year. The researchers say they now understand ... been in use for more than 50 years even though ... to the microbes it attacks. , A report of ...
(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
Breaking Medicine News(10 mins):Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Nano shake-up 2
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... 15, 2014  Manufacturers, suppliers and distributors of innovative ... protect their most important business assets, intellectual property ... Because of the highly-competitive nature of ... of the most litigious industry sectors of cases ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
Cached News: